Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > November 2015

« Previous month Next month »

Oramed inks China licensing deal for oral insulin candidate

30-Nov-2015 - Hefei will manufacture the API for Oramed's oral insulin tablet as part of a potential $50m licensing deal in China, Hong Kong and Macau.

Pfizer-Allergan merger

‘Over 90%’ of industry thinks Pfizer will sell generics biz

30-Nov-2015 - Pfizer says it will decide in 2018 whether to split its generics and branded businesses but M&A experts are already predicting how the giant will get rid of its established...


The latest pharma appointments

30-Nov-2015 -

ManKind plans to build manufacturing plant in the Himalayas

30-Nov-2015 - ManKind Pharma plans to set up manufacturing facilities in Northeast India to bring production in-house and cut its tax bill.

Complementary my dear Watson: biopharma tech firm buys Flow Smart for $5.3m

27-Nov-2015 - Watson-Marlow Fluid Technologies has bought Flow Smart for £5.7m ($5.3m) to bolster its biopharma-focused pump and fluid path tech portfolio.

Teva tackles migraine through potential $400m Heptares collaboration

26-Nov-2015 - Teva has teamed with Heptares to develop and commercialise easily-deliverable small-molecule calcitonin gene-related peptide (CGPR) antagonists to treat migraine.

Happy Thefts-giving: Drugmakers need to be extra vigilant during the holidays says expert

26-Nov-2015 - The number of pharmaceutical cargo thefts has fallen in recent years, but manufacturers still need to be vigilant according to an expert who says the holidays are a risky period.

Acquired Sigma-Aldrich businesses part of Merck's Africa growth plan

26-Nov-2015 - New acquisition Sigma Aldrich will play a part in African growth plans in addition to giving it a presence in the preclinical services sector says Merck*.

Novo Nordisk to switch to 100% renewable electricity

26-Nov-2015 - Novo Nordisk plans to switch all its production plants worldwide to renewable energy, including wind, by 2020.

FDA warning for Sandoz after data and training issues at Indian plants

25-Nov-2015 - Manipulated employee records and English-only training materials were among violations cited by the US FDA at two Indian plants, but Sandoz is confident these will be resolved.

Xellia buys ex-Ben Venue site and aims to restart production in 2017

25-Nov-2015 - Restarting production at the former Ben Venue facility in Ohio will be a “significant task” says Xellia Pharmaceuticals which plans to invest after buying the site from Hikma.

Seaweed shortage prompts Thermo to suspend sale of two lab agars

25-Nov-2015 - Thermofisher Scientific has stopped selling two agars used in pharmaceutical industry control labs, citing a worldwide shortage of the seaweed used to make them.

Eisai to sell clinical diagnostics supply business

25-Nov-2015 - Eisai will sell its clinical diagnostics business – EIDIA Co. Ltd - to Sekisui Chemical for JPY 22.4bn ($183m).

Ash Stevens to make API for Takeda's new oral blood cancer drug

24-Nov-2015 - The US FDA has cleared Ash Stevens to make the API for Takeda's new multiple myeloma drug Ninlaro, which is the first oral proteasome inhibitor to be approved in the...

EC mulls changes to Orphan Drug rules

24-Nov-2015 - Tweaks to EU orphan drug rules (OD) may be needed to accommodate Ebola treatment development and block industry attempts to delay generic entry says the European Commission.

AZ not worried about giving Sanofi a potential blockbuster in swap deal

24-Nov-2015 - AstraZeneca says it had no worries about giving rival Sanofi a potential blockbuster drug when the two exchanged compound library molecules this month. 

API sourcing leads US Gov to label Carlsbad's Acyclovir tablets as made in Asia

23-Nov-2015 - US Customs and Border Protection (CBP) says the country of origin of Carlsbad Technology’s acyclovir is where the API is sourced, not the US where the tablets are made.

Pfizer gets OK for $160bn Allergan acquisition

23-Nov-2015 - The boards of Pfizer and Allergan yesterday signed a $160bn merger that will create the world’s biggest pharmaceutical company.

'Drug-in-capsule' demand for trial material drives Juniper micro-dose investment

23-Nov-2015 - Juniper Pharmaceuticals has made a “significant capital investment” to expand its Xcelodose powder micro-dosing system to feed demand for Phase I study materials.

Strides Shasun restarts API production at fire struck plant

23-Nov-2015 - Strides Shasun has restarted some active pharmaceutical ingredient (API) production at a plant in Cuddalore, India after a fire last week.

Dispatches from PCT Europe

Future epidemic trials must cut through red tape, says Ebola researcher

19-Nov-2015 - A professor who conducted fast-track trials during last year’s Ebola outbreak says next time such trials must be part of humanitarian response… because there will be a next time.

Pharma unhappy with French 'made in EU' proposal

19-Nov-2015 - France's government has proposed new labelling for medicines that would indicate whether the contents were manufactured in or outside Europe.

Laser delivery will allow painless, needle-less vaccines

19-Nov-2015 - A laser-based treatment will allow powdered vaccines to be delivered through the skin, scientists say.


CEO who ‘only employs beautiful women’ guilty of sex discrimination

18-Nov-2015 - The CEO of Immuno Biotech who said he only employs “beautiful women” and noted a candidate’s lipstick and high heels on her job application has been fined for sex discrimination....

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...